Danaher: Charles Lamanna
Danaher announced that it has appointed Charles Lamanna to its board of directors and the board's science and technology committee. Lamanna is currently the corporate VP of business and industry at Microsoft, where he oversees product innovation in artificial intelligence-based business applications, low-code platforms, and autonomous agents. He previously was the founder and CEO of public cloud management solution MetricsHub, which Microsoft acquired in 2013.
VedaBio: Rachel Jones
VedaBio has appointed Rachel Jones as chief commercial officer to help advance the development and commercialization of its CRISPR-based molecular detection platform. Jones formerly served as CCO at Karius and BioFire Diagnostics.
Panome Bio: Jean-Pierre Wery
Panome Bio, a St. Louis-based omics-focused contract research organization, has added Jean-Pierre Wery to its board of directors. Wery has previously served as cofounder, director, president, and CEO of Sidewinder Therapeutics; chief technology officer at JSR Life Sciences; and CEO at Crown Bioscience, among other positions.
For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.